Mediterranean-style Dietary Pattern (MDP), Mood and Anxiety
MediMood
MediMood: A Randomised Controlled Trial Investigating the Acute Impact of a Plant Based Mediterranean-style Dietary Pattern (MDP) on Mood, Anxiety and Cognition in UK Adults With Mild to Moderate Mental Health Complaints
1 other identifier
interventional
25
1 country
1
Brief Summary
Observational studies and a limited numbers of RCTs have observed that habitual Mediterranean-style dietary pattern (MDP) consumption is associated with improved mental health and cognition. Yet, its efficacy in a short-term has not been studied in well-controlled intervention settings. MediMood is a cross-over RCT aiming to test whether a MDP can affect mood and anxiety following a meal (postprandial) and over 5-days in adults over 18 years with mild to moderate mental health problems relative to a Western diet (WD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedApril 3, 2025
May 1, 2024
5 months
March 2, 2023
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in mood
Established by the Bond-Lader visual analogue scale (includes 16 items each having antonyms on two ends, on a scale of 1 to 100, 50 being the neutral point)
Baseline (morning of day 1), Postprandial (after lunch on Established by the Bond-Lader visual analogue scale (includes 16 items each having day 1), 24-hours (morning of day 2), day 5 (morning of day 6 upon completion of 5 full days intervention)
Change in anxiety
Established by the Profile of Mood States (includes 65 items on a 5 point Likert scale)
Baseline (morning of day 1), Postprandial (after lunch on day 1), 24-hours (morning of day 2), day 5 (morning of day 6 upon completion of 5 full days intervention)
Secondary Outcomes (11)
Change in cognitive performance
Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
Cerebral blood flow
Postprandial day 1
Change in blood pressure
Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
Change in gut microbiota speciation
Baseline (morning of day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
Change in plasma short chain fatty acids (SCFA)
Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
- +6 more secondary outcomes
Other Outcomes (7)
Change in dietary behaviour
Screening and 3 months upon the completion
Change in plasma insulin
Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
Change in plasma glucose
Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)
- +4 more other outcomes
Study Arms (2)
Mediterranean-style dietary pattern
EXPERIMENTALA Mediterranean-style diet (as a whole diet, no supplements)
Western-style dietary pattern
ACTIVE COMPARATORA Western-style diet (as a whole diet, no supplements)
Interventions
All foods, meal plans and instructions provided.
Eligibility Criteria
You may qualify if:
- Male and female, aged 18 or above
- Is willing and able to comply with all study procedures, including changes in diets
- Has access to and able to use the internet/computer/tablet device
- Mild to moderate level of anxiety and/or depression symptoms, assessed by Generalised Anxiety disorder (GAD-7) score and Patient Health Questionnaire (PHQ-9), scores 5 to 14 on both questionnaires
- A habitual MEDAS score of ≤ 7/14
- To be fluent in English
You may not qualify if:
- MEDAS score \>7
- Vegan/vegetarian
- Allergies to one of the study components i.e. nuts, fish
- On antidepressant or antianxiety medication where dosage is likely to change over the next 3 month
- Factors precluding MRI scanning such as suffers from claustrophobia or has metal implants
- Not fluent in English
- Not agreement for the study team to contact the participants general practitioner about trial participation and screening results
- Not prepared to make changes to the diet for 10 days (2 x 5 day periods)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of East Anglialead
- Newcastle Universitycollaborator
Study Sites (1)
University of East Anglia
Norwich, Norfolk, NR4 7UQ, United Kingdom
Related Publications (1)
Esgunoglu L, Liaquat M, Gillings R, Lazar A, Leddy A, Brooks J, Penny W, Sami S, Hornberger M, Stevenson E, Jennings A, Minihane AM. Acute effect of a Mediterranean-style dietary pattern (MDP) on mood, anxiety and cognition in UK adults with mild to moderate anxiety and depression: the MediMood randomised controlled trial protocol. BMJ Open. 2024 Dec 20;14(12):e082935. doi: 10.1136/bmjopen-2023-082935.
PMID: 39806712DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Marie Minihane
University of East Anglia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2023
First Posted
July 3, 2023
Study Start
August 1, 2023
Primary Completion
December 15, 2023
Study Completion
June 30, 2024
Last Updated
April 3, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share